Global Allergy Immunotherapies Market Forecast To Reach At CAGR of 7.3% Between 2016-2020

About the Allergy Immunotherapies Market

Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the doses of allergen extracts over a span of time either through injections or sublingual tablets and drops.
Allergies occur when a foreign substance, which is mostly harmless, reacts with the immune system. These foreign substances are called allergens. Some allergens that affect the immune system are animal dander, dust mite, pollens, cockroach, and mold. Animal dander, dust mite, and mold cause indoor allergies.
There are various types of allergies, including rhinitis, asthma, eye allergy, and skin allergy. Sometimes, severe allergies can lead to death, as the severity of these allergic reactions interfere with the proper function of organs. For instance, allergic rhinitis and asthma cause the lungs to function poorly.

Technavios analysts forecast the global allergy immunotherapies market to grow at a CAGR of 7.3% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global allergy immunotherapies market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat allergic diseases such as allergic rhinitis and allergic asthma. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

Get Sample Copy of This Report: http://www.marketresearchreports.biz/sample/sample/746007

The market is divided into the following segments based on geography:
Europe
North America
ROW

Technavio's report, Global Allergy Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
ALK-Abello
Stallergenes
Merck Group
Allergy Therapeutics

Other prominent vendors
Adamis Pharmaceuticals
Aimmune Therapeutics
Anergis
ASIT biotech
Biomay
Circassia
DBV Technologies
Genentech
HAL Allergy
Laboratorios LETI
Mitsubishi Tanabe Pharma
Nycomed
Sementis
Shionogi
Torii
Tunitas Therapeutics
VentiRx Pharmaceuticals
Verona Pharma

Market driver
Presence of high unmet medical needs
For a full, detailed list, view our report

Market challenge
Poor patient adherence and high dropout rates
For a full, detailed list, view our report

Market trend
Advent of SPIRE
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
(USA-CANADA)

Tel: +1-518-621-2074
E: sales@marketresearchreports.biz

This release was published on openPR.